Clinical example of the drug pazopanib as a targeted therapy in inoperable cancer of the kidney

This article is a result of their own long-term observation of the patient treatment of inoperable cancer of the kidney. As first-line therapy pazopanib is used in standard dosage. The drug belongs to the new generation of drugs that block angiogenesis and having cytoreductive effect. During treatme...

Full description

Bibliographic Details
Main Authors: A A Klimenko, S A Ivanov
Format: Article
Language:Russian
Published: IP Habib O.N. 2013-12-01
Series:Современная онкология
Subjects:
Online Access:https://modernonco.orscience.ru/1815-1434/article/view/26927
Description
Summary:This article is a result of their own long-term observation of the patient treatment of inoperable cancer of the kidney. As first-line therapy pazopanib is used in standard dosage. The drug belongs to the new generation of drugs that block angiogenesis and having cytoreductive effect. During treatment, the stabilization of the disease. The results of treatment can be recommended for use pazopanib treatment of kidney cancer.
ISSN:1815-1434
1815-1442